215380 — Woojung BIO Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Woojung BIO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	280	-10,879	-1,926	-1,880	-5,054
Depreciation
Amortisation
Non-Cash Items	1,528	8,696	-1,047	623	2,225
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-2,974	-7,977	1,999	-488	-4,716
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	209	-8,575	1,728	2,502	-3,222
Capital Expenditures	-2,395	-16,639	-36,721	-11,510	-887
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-4,954	-1,673	7,285	5,323	1,023
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-7,349	-18,312	-29,437	-6,187	136
Financing Cash Flow Items	295	-83.8	173	-346	27.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	707	26,343	24,056	6,807	4,925
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-6,423	-596	-3,653	3,122	1,840